Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists

著者: Annenberg Center for Health Sciences
  • サマリー

  • In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. Drawing on seminal research and their own experience, cardiologist Jorge Plutzy, MD, and endocrinologist Helena Rodbard, MD, navigate through a series of ‘clinical questions’ to inform regarding the clinical pharmacology of the GLP-1RAs and their evidence-based role in cardiovascular risk reduction, particularly in patients with secondary atherosclerotic cardiovascular disease.
    Annenberg Center for Health Sciences
    続きを読む 一部表示

あらすじ・解説

In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. Drawing on seminal research and their own experience, cardiologist Jorge Plutzy, MD, and endocrinologist Helena Rodbard, MD, navigate through a series of ‘clinical questions’ to inform regarding the clinical pharmacology of the GLP-1RAs and their evidence-based role in cardiovascular risk reduction, particularly in patients with secondary atherosclerotic cardiovascular disease.
Annenberg Center for Health Sciences
エピソード
  • Cardiologist Collaboration
    2024/03/05
    • Role in Diabetes Management
    • Multidisciplinary Team-based Approach
    続きを読む 一部表示
    5 分
  • Individualizing Therapy
    2024/03/05
    • Drug Initiation and Monitoring
    • Contraindications and Adverse Effects
    • Patient Education
    続きを読む 一部表示
    8 分
  • Cardiovascular Benefits
    2024/03/05
    • FDA Indications
    • Clinical Trial Evidence

    続きを読む 一部表示
    4 分

Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonistsに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。